Joseph T. Wang

994 total citations
22 papers, 753 citations indexed

About

Joseph T. Wang is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Joseph T. Wang has authored 22 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Urology, 16 papers in Rheumatology and 15 papers in Epidemiology. Recurrent topics in Joseph T. Wang's work include Urinary Bladder and Prostate Research (20 papers), Pelvic floor disorders treatments (16 papers) and Urinary Tract Infections Management (15 papers). Joseph T. Wang is often cited by papers focused on Urinary Bladder and Prostate Research (20 papers), Pelvic floor disorders treatments (16 papers) and Urinary Tract Infections Management (15 papers). Joseph T. Wang collaborates with scholars based in United States, United Kingdom and Germany. Joseph T. Wang's co-authors include Zhonghong Guan, Steven A. Kaplan, Eric S. Rovner, Claus G. Roehrborn, Jeffrey P. Weiss, Roger R. Dmochowski, Marina Brodsky, Tamara Bavendam, Raymond R. Rackley and Stephen R. Kraus and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

Joseph T. Wang

21 papers receiving 724 citations

Peers

Joseph T. Wang
David Mitcheson United States
K. E. Whitmore United States
Salvador Arlandis Spain
Kevin Rademakers Netherlands
Philip E.V.A. van Kerrebroeck Netherlands
Gerhard Compion United Kingdom
Asha Paireddy United States
J J Wyndaele Belgium
G. Primus Austria
Budiwan Sumarsono South Korea
David Mitcheson United States
Joseph T. Wang
Citations per year, relative to Joseph T. Wang Joseph T. Wang (= 1×) peers David Mitcheson

Countries citing papers authored by Joseph T. Wang

Since Specialization
Citations

This map shows the geographic impact of Joseph T. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph T. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph T. Wang more than expected).

Fields of papers citing papers by Joseph T. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph T. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph T. Wang. The network helps show where Joseph T. Wang may publish in the future.

Co-authorship network of co-authors of Joseph T. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph T. Wang. A scholar is included among the top collaborators of Joseph T. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph T. Wang. Joseph T. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldman, Howard B., Jean‐Jacques Wyndaele, Steven A. Kaplan, Joseph T. Wang, & Fady Ntanios. (2013). Defining response and non-response to treatment in patients with overactive bladder: a systematic review. Current Medical Research and Opinion. 30(3). 509–526. 18 indexed citations
2.
Cardozo, Linda, Vik Khullar, Joseph T. Wang, Zhonghong Guan, & Peter K. Sand. (2010). Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?. British Journal of Urology. 106(6). 816–821. 23 indexed citations
3.
Kraus, Stephen R., et al.. (2010). Efficacy and Tolerability of Fesoterodine in Older and Younger Subjects With Overactive Bladder. Urology. 76(6). 1350–1357. 50 indexed citations
4.
Chapple, Christopher R., Sender Herschorn, Paul Abrams, et al.. (2010). Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration. British Journal of Urology. 106(9). 1332–1338. 22 indexed citations
5.
Herschorn, Sender, J. Stephen Jones, Matthias Oelke, et al.. (2009). Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies. Urology. 75(5). 1149–1155. 35 indexed citations
6.
Kerrebroeck, Philip E.V. van, Con Kelleher, Karin S. Coyne, et al.. (2009). Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health and Quality of Life Outcomes. 7(1). 13–13. 21 indexed citations
7.
Chapple, Christopher R., Philip E.V. van Kerrebroeck, Klaus‐Peter Jünemann, Joseph T. Wang, & Marina Brodsky. (2008). Comparison of fesoterodine and tolterodine in patients with overactive bladder. British Journal of Urology. 102(9). 1128–1132. 67 indexed citations
8.
Kelleher, Con, Andrea Tubaro, Joseph T. Wang, & Zoë Kopp. (2008). Impact of fesoterodine on quality of life: pooled data from two randomized trials. British Journal of Urology. 102(1). 56–61. 46 indexed citations
9.
Herschorn, Sender, John Heesakkers, David Castro‐Díaz, et al.. (2008). Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms. Current Medical Research and Opinion. 24(12). 3513–3521. 27 indexed citations
10.
Roehrborn, Claus G., Steven A. Kaplan, J. Stephen Jones, et al.. (2008). Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size. European Urology. 55(2). 472–481. 59 indexed citations
11.
Roehrborn, Claus G., Steven A. Kaplan, Stephen R. Kraus, et al.. (2008). Effects of Serum PSA on Efficacy of Tolterodine Extended Release With or Without Tamsulosin in Men With LUTS, Including OAB. Urology. 72(5). 1061–1067. 47 indexed citations
12.
Chapple, Christopher R., Philip Van Kerrebroeck, Andrea Tubaro, et al.. (2007). 1188: Efficacy of Fesoterodine in Patients with Overactive Bladder (OAB): Improvements in OAB Symptoms and Health-Related Quality of Life (HRQL). The Journal of Urology. 177(4S). 392–392. 1 indexed citations
13.
Weiss, Jeffrey P., et al.. (2007). Age Related Pathogenesis of Nocturia in Patients With Overactive Bladder. The Journal of Urology. 178(2). 548–551. 48 indexed citations
14.
Νitti, Victor W., Roger R. Dmochowski, Rodney A. Appell, et al.. (2006). Efficacy and tolerability of tolterodine extended‐release in continent patients with overactive bladder and nocturia. British Journal of Urology. 97(6). 1262–1266. 33 indexed citations
15.
Dmochowski, Roger R., Paul Abrams, Daniela Marschall‐Kehrel, Joseph T. Wang, & Zhonghong Guan. (2006). Efficacy and Tolerability of Tolterodine Extended Release in Male and Female Patients with Overactive Bladder. European Urology. 51(4). 1054–1064. 50 indexed citations
16.
Kaplan, Steven A., Claus G. Roehrborn, Roger R. Dmochowski, et al.. (2006). Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 68(2). 328–332. 63 indexed citations
17.
Rackley, Raymond R., Jeffrey P. Weiss, Eric S. Rovner, Joseph T. Wang, & Zhonghong Guan. (2006). Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 67(4). 731–736. 100 indexed citations
18.
Wein, Alan J., Vik Khullar, Joseph T. Wang, & Zhonghong Guan. (2006). Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration. British Journal of Urology. 99(2). 360–363. 14 indexed citations
19.
Wang, Joseph T., et al.. (2002). Cost savings in migraine associated with less chest pain on new triptan therapy.. PubMed. 8(3 Suppl). S102–7. 9 indexed citations
20.
Wang, Joseph T., et al.. (2002). Impact of Chest Pain on Cost of Migraine Treatment With Almotriptan and Sumatriptan. Headache The Journal of Head and Face Pain. 42(s1). 38–43. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Mitcheson Breakdown of academic impact, for papers by K. E. Whitmore Breakdown of academic impact, for papers by Salvador Arlandis Breakdown of academic impact, for papers by Kevin Rademakers Breakdown of academic impact, for papers by Philip E.V.A. van Kerrebroeck Breakdown of academic impact, for papers by Gerhard Compion Breakdown of academic impact, for papers by Asha Paireddy Breakdown of academic impact, for papers by J J Wyndaele Breakdown of academic impact, for papers by G. Primus Breakdown of academic impact, for papers by Budiwan Sumarsono
Rankless by CCL
2026